NovaBay Pharmaceuticals, Inc.

NYSEAM:NBY Rapport sur les actions

Capitalisation boursière : US$3.7m

NovaBay Pharmaceuticals Bilan de santé

Santé financière contrôle des critères 2/6

NovaBay Pharmaceuticals has a total shareholder equity of $-617.0K and total debt of $696.0K, which brings its debt-to-equity ratio to -112.8%. Its total assets and total liabilities are $3.9M and $4.5M respectively.

Informations clés

-112.8%

Ratio d'endettement

US$696.00k

Dette

Ratio de couverture des intérêtsn/a
Argent liquideUS$751.00k
Fonds propres-US$617.00k
Total du passifUS$4.54m
Total des actifsUS$3.93m

Mises à jour récentes de la santé financière

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Recent updates

We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Mar 29
We Think NovaBay Pharmaceuticals (NYSEMKT:NBY) Can Afford To Drive Business Growth

Analyse de la situation financière

Passif à court terme: NBY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Passif à long terme: NBY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Historique et analyse du ratio d'endettement

Niveau d'endettement: NBY has negative shareholder equity, which is a more serious situation than a high debt level.

Réduire la dette: NBY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Bilan


Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: NBY has sufficient cash runway for 3 months based on last reported free cash flow, but has since raised additional capital.

Prévisions de trésorerie: NBY is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.


Découvrir des entreprises saines